Tekla Capital Management LLC Amgen Inc Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 616,539 shares of AMGN stock, worth $199 Million. This represents 5.42% of its overall portfolio holdings.

Number of Shares

616,539

Previous 555,939 10.9%

Holding current value

$199 Million

Previous $134 Million 1.85%

% of portfolio

5.42%

Previous 5.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $13 Million - $15.4 Million	60,600 Added 10.9%	616,539 $137 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $10.7 Million - $13 Million	47,263 Added 9.29%	555,939 $134 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $2.33 Million - $2.97 Million	-10,193 Reduced 1.96%	508,676 $134 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $6.63 Million - $7.48 Million	-29,549 Reduced 5.39%	518,869 $117 Million
Q2 2022 Jul 29, 2022	SELL	$230.71 - $256.74 $6.11 Million - $6.8 Million	-26,500 Reduced 4.61%	548,418 $133 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $23.7 Million - $27.7 Million	111,513 Added 24.06%	574,918 $122 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $10.9 Million - $12.1 Million	46,845 Added 11.25%	463,405 $113 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $41.5 Million - $49.4 Million	-191,658 Reduced 31.51%	416,560 $95.8 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $878,529 - $976,996	-3,744 Reduced 0.61%	608,218 $155 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $2.39 Million - $2.93 Million	12,091 Added 2.02%	611,962 $144 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $3.2 Million - $4.24 Million	-17,556 Reduced 2.84%	599,871 $122 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $2.81 Million - $3.61 Million	-14,860 Reduced 2.35%	617,427 $149 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $17 Million - $20.3 Million	-97,371 Reduced 13.34%	632,287 $122 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $4.21 Million - $4.94 Million	25,275 Added 3.59%	729,658 $134 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $4.8 Million - $5.41 Million	26,528 Added 3.91%	704,383 $134 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $4.21 Million - $4.75 Million	-22,733 Reduced 3.24%	677,855 $141 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $27.4 Million - $32 Million	-161,586 Reduced 18.74%	700,588 $119 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $40.8 Million - $45.6 Million	241,900 Added 39.0%	862,174 $150 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $10.8 Million - $12.3 Million	-64,550 Reduced 9.43%	620,274 $116 Million
Q2 2017 Aug 14, 2017	BUY	N/A	684,824	684,824 $118 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Amgen Inc Transaction History